NCT04257032View on ClinicalTrials.gov

A Study in Healthy Men to Test the Influence of BI 1323495 on the Amount of the Medicines Rosuvastatin and Dabigatran in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 13, 2020

Primary Completion Date

September 23, 2020

Study Completion Date

September 23, 2020

Conditions
Healthy
Interventions
DRUG

Rosuvastatin

Tablet

DRUG

Rosuvastatin + BI 1323495

Tablets

DRUG

Dabigatran etexilate

Capsule

DRUG

Dabigatran etexilate + BI 1323495

Capsule and tablets

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04257032 - A Study in Healthy Men to Test the Influence of BI 1323495 on the Amount of the Medicines Rosuvastatin and Dabigatran in the Blood | Biotech Hunter | Biotech Hunter